Ensign Peak Advisors
JNJ icon

Ensign Peak Advisors’s Johnson & Johnson JNJ Stock Holding History

Ensign Peak Advisors’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$524M Buy
2,064,646
+98,877
+5% +$23M 0.86% 19
2026
Q1 		$481M Sell
1,965,769
-160,240
-8% -$37.3M 0.9% 15
2025
Q4 		$440M Sell
2,126,009
-352,322
-14% -$69.7M 0.78% 19
2025
Q3 		$460M Sell
2,478,331
-57,661
-2% -$9.88M 0.75% 20
2025
Q2 		$387M Buy
2,535,992
+59,609
+2% +$9.16M 0.66% 23
2025
Q1 		$411M Buy
2,476,383
+708,364
+40% +$111M 0.79% 21
2024
Q4 		$256M Sell
1,768,019
-56,209
-3% -$8.71M 0.45% 45
2024
Q3 		$296M Sell
1,824,228
-29,840
-2% -$4.75M 0.52% 35
2024
Q2 		$271M Sell
1,854,068
-118,455
-6% -$17.6M 0.5% 38
2024
Q1 		$312M Sell
1,972,523
-335,258
-15% -$53.4M 0.57% 35
2023
Q4 		$362M Sell
2,307,781
-782,901
-25% -$120M 0.72% 25
2023
Q3 		$481M Sell
3,090,682
-892,062
-22% -$147M 1.03% 15
2023
Q2 		$659M Sell
3,982,744
-421,030
-10% -$68M 1.34% 12
2023
Q1 		$683M Sell
4,403,774
-130,903
-3% -$21.1M 1.48% 9
2022
Q4 		$801M Sell
4,534,677
-206,882
-4% -$35.7M 1.8% 6
2022
Q3 		$775M Sell
4,741,559
-20,095
-0.4% -$3.4M 1.92% 6
2022
Q2 		$845M Buy
4,761,654
+472,425
+11% +$84.2M 2.01% 6
2022
Q1 		$760M Buy
4,289,229
+1,095,909
+34% +$186M 1.54% 7
2021
Q4 		$546M Buy
3,193,320
+490,872
+18% +$80.4M 1.04% 11
2021
Q3 		$436M Sell
2,702,448
-331,270
-11% -$56.5M 0.91% 15
2021
Q2 		$500M Sell
3,033,718
-156,113
-5% -$25.8M 1.01% 12
2021
Q1 		$524M Sell
3,189,831
-182,290
-5% -$29.5M 1.13% 10
2020
Q4 		$531M Buy
3,372,121
+242,743
+8% +$35.8M 1.2% 8
2020
Q3 		$466M Sell
3,129,378
-433,648
-12% -$64.2M 1.18% 9
2020
Q2 		$501M Sell
3,563,026
-800,193
-18% -$117M 1.36% 8
2020
Q1 		$572M Sell
4,363,219
-64,870
-1% -$9.2M 1.92% 5
2019
Q4 		$646M Buy
+4,428,089
New +$601M 1.71% 5

Other funds holding JNJ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Ensign Peak Advisors's JNJ Position: Q2 2026 in Review

Ensign Peak Advisors increased its Johnson & Johnson (JNJ) stake by 5% in Q2 2026, buying an estimated $23M and bringing the position to 2,064,646 shares worth $524M. The position accounts for 0.86% of the portfolio, ranked #19.

Ensign Peak Advisors first reported a position in JNJ in Q4 2019 and has held it in 27 quarters since. The position peaked at $845M in Q2 2022. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Ensign Peak Advisors held 2,064,646 shares of Johnson & Johnson worth $524M as of Q2 2026.
  • Ensign Peak Advisors bought 98,877 Johnson & Johnson shares in Q2 2026, an estimated $23M.
  • Johnson & Johnson made up 0.86% of Ensign Peak Advisors's portfolio in Q2 2026, its #19 holding.
  • Ensign Peak Advisors first reported a position in Johnson & Johnson in Q4 2019 and has held it in 27 quarters since.
  • Ensign Peak Advisors's Johnson & Johnson position peaked at $845M in Q2 2022.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.